These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7581125)

  • 21. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study.
    Michon J; Négrier S; Coze C; Mathiot C; Frappaz D; Oskam R; Pacquement H; Quintana E; Bouffet E; Bernard JL
    Prog Clin Biol Res; 1994; 385():293-300. PubMed ID: 7972223
    [No Abstract]   [Full Text] [Related]  

  • 23. Late development of graft-versus-host disease in an autologous BMT recipient.
    Appleton AL; Sviland L; Wilkes J; Pearson AD; Malcolm AJ
    Bone Marrow Transplant; 1994 Jun; 13(6):823-5. PubMed ID: 7920321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
    Bonnotte B; Burdiles AM; Chehimi J; Carayol G; Pardoux C; Dietrich PY; Kubin M; Blay JY; Caignard A; Ibrahim A; Robinet E; Hayat M; Pico JL; Bourhis JH; Chouaib S
    Eur Cytokine Netw; 1996 Sep; 7(3):389-94. PubMed ID: 8954182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased graft-versus-host disease after haplotype mismatched bone marrow allografts in miniature swine following interleukin-2 treatment.
    Kozlowski T; Sablinski T; Basker M; Kitamura H; Spitzer TR; Fishman J; Sykes M; Cooper DK; Sachs DH
    Bone Marrow Transplant; 2000 Jan; 25(1):47-52. PubMed ID: 10654014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultraviolet irradiation for the prevention of graft-versus-host disease and graft rejection in bone marrow transplantation.
    Hudson JG; Lawler M; Pamphilon DH
    Bone Marrow Transplant; 1994 Oct; 14(4):511-6. PubMed ID: 7858525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eruption of lymphocyte recovery or autologous graft-versus-host disease?
    Nellen RG; van Marion AM; Frank J; Poblete-Gutiérrez P; Steijlen PM
    Int J Dermatol; 2008 Nov; 47 Suppl 1():32-4. PubMed ID: 18986483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
    Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
    Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
    Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
    Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
    Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
    Bone Marrow Transplant; 1999 Sep; 24(6):637-40. PubMed ID: 10490729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
    Ziemer M; Thiele JJ; Gruhn B; Elsner P
    J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute myeloblastic leukaemia: graft-versus-host and graft-versus-leukaemia responses to autologous IL-2 activated lymphocytes in rapid and slow disease.
    Boughton BJ; Simpson AW
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):1-6. PubMed ID: 10390074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose interleukin-2 therapy is not associated with cutaneous toxicity after autologous transplantation.
    López-Jiménez J; De las Heras E; Hilara Y; García-Laraña J; Pérez-Oteyza J; Bellas C; Muñoz A; Rocamora A; Núñez M; Odriozola J
    Bone Marrow Transplant; 1996 Aug; 18(2):481-2. PubMed ID: 8864471
    [No Abstract]   [Full Text] [Related]  

  • 36. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
    Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
    Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PUVA therapy for cutaneous acute graft-versus-host disease--a case report].
    Inamitsu T; Inoue M; Akiyoshi H; Honda K; Shibuya T; Nakayama H; Ueda K
    Rinsho Ketsueki; 1995 Nov; 36(11):1321-5. PubMed ID: 8691576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow transplantation.
    Armitage JO
    N Engl J Med; 1994 Mar; 330(12):827-38. PubMed ID: 8114836
    [No Abstract]   [Full Text] [Related]  

  • 39. Atypical acute graft-versus-host disease.
    Shin J; Hong W; Song H; Choi G; Kim YC
    Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syngeneic graft-vs-host disease.
    Ferrara JL
    Arch Dermatol; 1987 Jun; 123(6):741-2. PubMed ID: 3555352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.